Physician profile
Artyom Abramyan
NPI 1861846685
$1,678.43
in general payments reported to CMS, 2019-2025
10 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $733 · 2023: $641 · 2024: $121 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $945.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $357.10 | 2022 | |
| Penumbra, INC. | $312.16 | 2023-2025 | Indigo System, Penumbra System |
| Stryker Corporation | $290.40 | 2022-2025 | Clottriever Bold Catheter |
| Terumo Medical Corporation | $254.05 | 2022-2023 | Azur Cx Detachable |
| Inari Medical, INC. | $193.73 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cook Medical LLC | $108.51 | 2023 | Zilver Ptx |
| W. L. Gore & Associates, INC. | $102.93 | 2023 | Viatorr Endoprosthesis |
| Medtronic, INC. | $23.95 | 2022 | |
| Imperative Care, INC | $22.74 | 2025 | Symphony Catheter |
| Bard Peripheral Vascular, INC. | $12.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Artyom Abramyan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.